Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06557499 · ClinicalTrials.gov registry record · NA
A 3-way Crossover Clinical Investigation to Assess the Performance of Two Different Sized Polyurethane Condoms Versus a Latex Condom in Healthy Monogamous Couples.
A NA study of Contraception, sponsored by Reckitt Benckiser Healthcare (UK) Limited.
- Recruiting
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 3
- Study locations
NCT06557499 is a NA study of Contraception that is actively recruiting participants, run by Reckitt Benckiser Healthcare (UK) Limited. The registered enrollment target is 600 participants, above the 446-participant average among 72 other Contraception trials with a reported enrollment target (35% higher). The trial reports 3 study locations across 2 states.
The verdict
NCT06557499, a NA study of Contraception, is actively recruiting participants, sponsored by Reckitt Benckiser Healthcare (UK) Limited.
- RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 3
- Study locations
Study Summary
This investigation is designed to evaluate the performance rate of two polyurethane male condoms with different sizes and thicknesses versus a standard natural rubber latex (NRL) male condom. The purpose of this study is to see how well the experimental condoms perform compared to the latex rubber condom (for example, how often the different condom types break or slip off the penis). Sponsor also wants to find out how well couples like using the three condom types and whether they experience any problems when using the condoms (for example, irritation or discomfort).
Conditions Studied
Interventions
- DEVICE Polyurethane (PU) male condom-Test condom 1
- DEVICE Polyurethane (PU) male condom-Test condom 2
- DEVICE Natural Rubber Latex (NRL) male condom- Control condom
Study Locations (3)
California
- Essential Access Health-Berkeley - Berkeley
- Essential Access Health -Los Angeles - Los Angeles
Washington
- Essential Acess Health- Seattle - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2024-08-23 |
| Est. Completion | 2025-05-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06557499
The ClinicalTrials.gov registry entry for NCT06557499 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 446-participant average among 72 other Contraception trials with a reported enrollment target (35% higher). The listed sponsor is Reckitt Benckiser Healthcare (UK) Limited, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 3 interventions - of which Polyurethane (PU) male condom-Test condom 1 is the first listed.
NCT06557499 reports 3 study locations spanning 2 distinct geographic areas - top geographies include California, Washington.
Frequently Asked Questions
What is clinical trial NCT06557499 about?
NCT06557499 is a clinical study titled "A 3-way Crossover Clinical Investigation to Assess the Performance of Two Different Sized Polyurethane Condoms Versus a Latex Condom in Healthy Monogamous Couples.". This investigation is designed to evaluate the performance rate of two polyurethane male condoms with different sizes and thicknesses versus a standard natural rubber latex (NRL) male condom. The purpose of this study is to see how well the experimental condoms perform compared to the latex rubber ...
What is the current status of trial NCT06557499?
This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2024-08-23. Estimated completion is 2025-05-19.
What conditions does trial NCT06557499 study?
This clinical trial studies the following conditions: Contraception.
What interventions are being tested in trial NCT06557499?
The interventions under investigation include: Polyurethane (PU) male condom-Test condom 1 (DEVICE), Polyurethane (PU) male condom-Test condom 2 (DEVICE), Natural Rubber Latex (NRL) male condom- Control condom (DEVICE).
Who is sponsoring clinical trial NCT06557499?
This trial is sponsored by Reckitt Benckiser Healthcare (UK) Limited, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06557499 being conducted?
This trial has 3 study locations across California, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
RECRUITING · NA
-
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
RECRUITING · NA
-
Contraceptive Efficacy Study of Ovaprene
RECRUITING · NA
-
Intervening on Women's Health for Rural Young Cancer Survivors
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.